LIP
BIIB icon

Liontrust Investment Partners’s Biogen BIIB Stock Holding History

Liontrust Investment Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,921
Closed -$445K – 215
2024
Q3 		$445K Hold
1,921
– – 0.01% 191
2024
Q2 		$445K Sell
1,921
-10,198
-84% -$2.22M 0.01% 191
2024
Q1 		$2.61M Sell
12,119
-1,484
-11% -$348K 0.04% 142
2023
Q4 		$3.52M Sell
13,603
-90
-0.7% -$22.1K 0.05% 127
2023
Q3 		$3.52M Buy
13,693
+10,379
+313% +$2.78M 0.06% 125
2023
Q2 		$944K Buy
3,314
+598
+22% +$178K 0.01% 194
2023
Q1 		$755K Buy
+2,716
New +$752K 0.01% 181
2022
Q4 		– Sell
-4,900
Closed -$1.31M – 192
2022
Q3 		$1.31M Buy
+4,900
New +$1.04M 0.02% 206

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Liontrust Investment Partners's BIIB Position: Q4 2024 in Review

Liontrust Investment Partners sold out of Biogen (BIIB) in Q4 2024, closing a stake of 1,921 shares — an estimated $445K sold.

Liontrust Investment Partners first reported a position in BIIB in Q3 2022 and held it in 8 quarters. The position peaked at $3.52M in Q4 2023. 874 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Liontrust Investment Partners reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Liontrust Investment Partners sold 1,921 Biogen shares in Q4 2024, an estimated $445K.
  • Liontrust Investment Partners first reported a position in Biogen in Q3 2022 and held it in 8 quarters.
  • Liontrust Investment Partners's Biogen position peaked at $3.52M in Q4 2023.
  • 874 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Liontrust Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.